US$ 24.75
l-carnitine dosage with mitochondrial disease The Importance of the Fatty Acid Transporter in Non-Alcoholic Fatty Liver (NAFLD) Role of L-carnitine in Cardiovascular
Description

acceptance of the final version: all authors

921 - 932 Copyright The Author(s), 2022

Cost is the main drawback to liquid supplements

-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO
